Compare, Analyse Suven Life Sciences with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   ACTAVIS
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
ACTAVIS
Dec-18
SUVEN LIFE SCIENCES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs33814,449-   
Low Rs1699,692-   
Sales per share (Unadj.) Rs52.13,544.2-  
Earnings per share (Unadj.) Rs6.8-1,141.6-  
Cash flow per share (Unadj.) Rs8.6373.5-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.314,618.3-  
Shares outstanding (eoy) m127.28332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.4 142.8%   
Avg P/E ratio x37.1-10.6 -351.1%  
P/CF ratio (eoy) x29.632.3 91.5%  
Price / Book Value ratio x3.90.8 470.3%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2724,014,617 0.8%   
No. of employees `0001.116.9 6.4%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.269,752.4 8.8%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.5-22,467.3 -3.6%   
INCOME DATA
Net Sales Rs m6,6351,178,815 0.6%  
Other income Rs m24222,543 1.1%   
Total revenues Rs m6,8771,201,358 0.6%   
Gross profit Rs m1,60430,891 5.2%  
Depreciation Rs m221503,918 0.0%   
Interest Rs m3868,024 0.1%   
Profit before tax Rs m1,587-518,508 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0132,241 0.0%   
Tax Rs m718-6,571 -10.9%   
Profit after tax Rs m869-379,697 -0.2%  
Gross profit margin %24.22.6 922.6%  
Effective tax rate %45.21.3 3,569.1%   
Net profit margin %13.1-32.2 -40.7%  
BALANCE SHEET DATA
Current assets Rs m6,232483,488 1.3%   
Current liabilities Rs m1,490427,710 0.3%   
Net working cap to sales %71.54.7 1,510.5%  
Current ratio x4.21.1 370.0%  
Inventory Days Days8620 441.3%  
Debtors Days Days8366 124.6%  
Net fixed assets Rs m4,043133,435 3.0%   
Share capital Rs m1270-   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,3104,862,062 0.2%   
Long term debt Rs m181,712,108 0.0%   
Total assets Rs m10,3897,600,510 0.1%  
Interest coverage x43.1-6.6 -650.9%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.2 411.8%   
Return on assets %8.7-4.1 -212.9%  
Return on equity %10.5-7.8 -134.0%  
Return on capital %19.5-4.8 -403.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356421,146 0.1%  
From Investments Rs m-279231,365 -0.1%  
From Financial Activity Rs m-225-722,813 0.0%  
Net Cashflow Rs m-148-69,951 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.67 Rs / USD

Compare SUVEN LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE SCIENCES With: PANACEA BIOTECH  JUBILANT PHARMOVA   PROCTER & GAMBLE HEALTH  NEULAND LABS  STERLING BIOTECH  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views On News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFE SCIENCES SHARE PRICE


Apr 9, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS